Ghent University Academic Bibliography

Your filters: cql: author="Pandit-Abid, Nami" or (type any "bookEditor issueEditor" and editor="Pandit-Abid, Nami")

Add to list
- Journal Article
- A1
- open access
Dupilumab induces long-term on-treatment clinical remission in patients with type 2 asthma

Ian D. Pavord, Klaus F. Rabe, Elliot Israel, Stanley J. Szefler, Guy Brusselle (UGent) , Nami Pandit-Abid, Arman Altincatal, Zhen Chen, Nikhil Amin, Asif H. Khan, et al.

(2025) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 13(1). p.132-142
Add to list
- Journal Article
- A1
- open access
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose

Christian Domingo, Klaus F Rabe, David Price, Guy Brusselle (UGent) , Michael E. Wechsler, Changming Xia, Nami Pandit-Abid, Rebecca Gall, Paul J. Rowe, Yamo Deniz, et al.

(2023) ERJ OPEN RESEARCH. 9(6).
Add to list
- Journal Article
- A1
- open access
Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies

Bob Geng, Claus Bachert (UGent) , William W. Busse, Philippe Gevaert (UGent) , Stella E. Lee, Michael S. Niederman, Zhen Chen, Xin Lu, Faisal A. Khokhar, Upender Kapoor, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(3). p.732-741
Add to list
- Conference Paper
- C3
Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma

Lawrence Sher, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Santiago Quirce, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan and Yi Zhang

(2021) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 58(supplement 65).
Add to list
- Conference Paper
- C3
Effect of dupilumab on improving physical activity in patients with severe asthma

Lawrence Sher, Santiago Quirce, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan and Yi Zhang

(2021) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 58(supplement 65).
Add to list
- Conference Paper
- C3
Dupilumab reduces severe outpatient asthma exacerbations, cumulative dose, and total number of days of systemic corticosteroid use among patients with moderate-to-severe type-2 asthma

Giorgio Walter Canonica, Robert Zeiger, Mario Castro, Jerome Msihid, Benjamin Ortiz, Nami Pandit-Abid, Siddhesh Kamat and Asif H. Khan

(2020) CHEST. In Chest 158(4). p.A1810-A1812
Add to list
- Conference Paper
- C3
Effect of Dupilumab on patient-reported breathing and rescue medication use

Jonathan Corren, Mario Castro, Jorge F Maspero, William W Busse, Antonio Valero Santiago, Piotr Kuna, Nadia Daizadeh, Nami Pandit-Abid, Benjamin Ortiz, Asif H. Khan, et al.

(2020) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 56(supplement 64).
Add to list
- Conference Paper
- C3
Dupilumab improves patient-reported breathing in oral corticosteroid-dependent severe asthma

Lawrence Sher, Robert Wolfe, Santiago Quirce, Lauren Cohn, Giovanni Passalacqua, Pierluigi Paggiaro, Camille Taillé, Nadia Daizadeh, Benjamin Ortiz, Nami Pandit-Abid, et al.

(2020) CHEST. 158(4). p.A1752-A1754

Academic Bibliography

Dupilumab induces long-term on-treatment clinical remission in patients with type 2 asthma

Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose

Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies

Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma

Effect of dupilumab on improving physical activity in patients with severe asthma

Dupilumab reduces severe outpatient asthma exacerbations, cumulative dose, and total number of days of systemic corticosteroid use among patients with moderate-to-severe type-2 asthma

Effect of Dupilumab on patient-reported breathing and rescue medication use

Dupilumab improves patient-reported breathing in oral corticosteroid-dependent severe asthma

Contents

Support

Contact